Results 151 to 160 of about 367,035 (204)
Impact of hepatic steatosis and MOLLI acquisition parameters on liver T1 estimates. [PDF]
Abdom Radiol (NY)Pednekar AS +6 more
europepmc +1 more source
MHY5456, an FXR Agonist, Ameliorates Hepatic Steatosis and Fibrosis in a Mouse Model of MASLD. [PDF]
Biomol Ther (Seoul)Kim MJ +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Clinical Nutrition & Metabolic Care, 2016
The high worldwide prevalence of nonalcoholic fatty liver disease (NAFLD) makes it a major public health issue. Amino acids offer a promising approach for its prevention, and several experimental studies highlight the nutritional importance of citrulline in this setting.
Prasanthi, Jegatheesan +1 more
openaire +3 more sources
The high worldwide prevalence of nonalcoholic fatty liver disease (NAFLD) makes it a major public health issue. Amino acids offer a promising approach for its prevention, and several experimental studies highlight the nutritional importance of citrulline in this setting.
Prasanthi, Jegatheesan +1 more
openaire +3 more sources
Seminars in Liver Disease, 2001
Hepatic steatosis is a common finding encountered during cross-sectional imaging examinations. This article reviews the imaging findings of hepatic steatosis as revealed by sonography, computed tomography, magnetic resonance imaging, and magnetic resonance spectroscopy.
Evan S Siegelman, E S Siegelman
exaly +3 more sources
Hepatic steatosis is a common finding encountered during cross-sectional imaging examinations. This article reviews the imaging findings of hepatic steatosis as revealed by sonography, computed tomography, magnetic resonance imaging, and magnetic resonance spectroscopy.
Evan S Siegelman, E S Siegelman
exaly +3 more sources
Archives of Medical Research, 2007
Hepatitis C infection and non-alcohol-related hepatic steatosis are the most common liver diseases worldwide, and both conditions often co-exist in the same patient. Hepatitis C virus (HCV) genotype 3 directly induces development of steatosis, whereas in patients with non-genotype 3 chronic hepatitis C infection, insulin resistance plays a key role in ...
Einar, Björnsson, Paul, Angulo
openaire +2 more sources
Hepatitis C infection and non-alcohol-related hepatic steatosis are the most common liver diseases worldwide, and both conditions often co-exist in the same patient. Hepatitis C virus (HCV) genotype 3 directly induces development of steatosis, whereas in patients with non-genotype 3 chronic hepatitis C infection, insulin resistance plays a key role in ...
Einar, Björnsson, Paul, Angulo
openaire +2 more sources
Patomechanisms of hepatic steatosis
Orvosi Hetilap, 2010Az elhízás és hozzá társuló kórállapotok, így az inzulinrezisztenciát kísérő nem alkoholos zsírmájbetegség a világ egészségügyi rendszereire jelentős terhet rónak. A betegség kialakulásának első lépése a májban történő trigliceridlerakódást kísérő elzsírosodás, amely később gyulladáshoz, illetve májzsugorhoz és májrákhoz is vezethet.
Péter, Fülöp, György, Paragh
openaire +2 more sources
Clinics in Liver Disease, 2004
Steatosis is a common finding in patients with chronic hepatitis C (CHC) due to a combination of the direct steatogenic effect of hepatitis C virus (HCV) and the prevalence of metabolic risk factors in the HCV population. Steatosis is now established as a risk factor for disease progression in CHC and significantly impacts therapeutic response ...
Anouk, Dev +2 more
openaire +2 more sources
Steatosis is a common finding in patients with chronic hepatitis C (CHC) due to a combination of the direct steatogenic effect of hepatitis C virus (HCV) and the prevalence of metabolic risk factors in the HCV population. Steatosis is now established as a risk factor for disease progression in CHC and significantly impacts therapeutic response ...
Anouk, Dev +2 more
openaire +2 more sources
A Girl with Photosensitivity and Hepatic Steatosis
The Journal of Pediatrics, 2014N ...
Pavan M. +5 more
openaire +4 more sources
Sphingolipids and Hepatic Steatosis
2011The development of a fatty liver predisposes individuals to an array of health problems including diabetes, cardiovascular disease and certain forms of cancer. Inhibition or genetic ablation of genes controlling sphingolipid synthesis in rodents resolves hepatic steatosis and in many cases wards off the health complications associated with excessive ...
Benjamin T, Bikman, Scott A, Summers
openaire +2 more sources